Peanut allergy sufferers know they need to stay away from certain foods that can put them in danger. But what about accidental exposure? Even trace amounts of peanut protein in their food or someone else’s can trigger an allergic reaction that sends them to the hospital.
That’s what makes Palforzia, an experimental peanut allergy treatment from Aimmune Therapeutics (NASDAQ: AIMT), a potentially big deal. Palforzia could become the first FDA-approved therapy that reduces peanut sensitivity enough to make those allergic reactions less frequent and less severe. The agency is expected to make an approval decision in January, but only after… Read more »
UNDERWRITERS AND PARTNERS